In line for breastfeeding mothers: A new study by Tel Aviv University and Ichilov Hospital states that giving the Corona vaccine to breastfeeding women encourages the production of important antibodies in breast milk that may contribute to the protection of the breastfed baby.
The leading team of researchers at Tel Aviv University included Dr. Yariv Wein and doctoral student Aya Kegel from the Shmonis School of Biomedical and Cancer Research, Faculty of Life Sciences. Liss Maternity and Women’s Hospital, Tel Aviv Medical Center, research team Led by Dr. Michal Rosenberg Friedman and Prof. Ariel Mani.
According to the researchers, the aim of the study was to determine whether Pfizer’s corona vaccine is effective in producing antibodies in breast milk and what the qualities of these antibodies are (ie whether they have the ability to neutralize the virus). The study was conducted in January-February, close to the arrival of the vaccines in Israel. The study included 10 breastfeeding women. The volunteers received the Corona vaccine in two doses with a difference of 21 days and the antibody levels in the blood and milk were tested at 4 points long after the vaccination.
Dr. Yariv Wayne (Photo: Tel Aviv University Spokeswoman)- Maariv-Jerusalem Post Conference: The Money Time Before the Election
The study shows that the increase in the levels of antibodies specific for the vaccine is well synchronized between the blood and milk. The significant increase in blood and milk occurs 14 days after the first dose, and continues to increase 7 days after the second dose. The researchers also found that the antibodies that develop in milk have the ability to neutralize, that is, have the ability to block the binding of the virus to the receptor on the storage cell and are important for preventing disease.
Dr. Wayne: “Overall, the encouraging data show that giving the Corona vaccine to breastfeeding women encourages the production of important antibodies in breast milk that may contribute to the protection of the breastfed baby.”
The article is currently under peer review. To read, click here.